Table 1.
Socio-demographic differences between participants with and without information on sexual orientation.
Unweighted frequencies and weighted percentages.
Table 2.
Unweighted frequencies and weighted percentages of socio-demographic characteristics, chronic conditions and health-related behaviors of LGB individuals and heterosexual counterparts in the 2011 Barcelona Health Interview Survey.
Table 3.
Censored linear regression models (Tobit model) with the EQ-5D index as the dependent variable.
Fig 1.
Prevalence ratios and 95% Confidence Intervals (65%CI) by sexual orientation for each physical EQ-5D dimension, considering different adjustment variables.
The EQ-5D dimension (dependent variable) was dichotomized into: no problems vs moderate/extreme problems. Model 1: Crude prevalence ratio. Model 2: Adjusted by age and gender. Model 3: Adjusted by age and gender + sociodemographic variables (education level, country of birth, and married or in sentimental partnership). Model 4: Adjusted by age and gender + sociodemographic variables + number of chronic conditions. Model 5: Adjusted by age and gender + sociodemographic variables + number of chronic conditions + health-related behaviors (smoking status, alcohol consumption, and psychoactive drug consumption).
Fig 2.
Prevalence ratios and 95% Confidence Intervals (65%CI) by sexual orientation for each mental EQ-5D dimension stratified by gender, considering different adjustment variables.
The EQ-5D dimension (dependent variable) was dichotomized into: no problems vs moderate/extreme problems. Model 1: Crude prevalence ratio. Model 2: Adjusted by age and gender. Model 3: Adjusted by age and gender + sociodemographic variables (education level, country of birth, and married or in sentimental partnership). Model 4: Adjusted by age and gender + sociodemographic variables + number of chronic conditions. Model 5: Adjusted by age and gender + sociodemographic variables + number of chronic conditions + health-related behaviors (smoking status, alcohol consumption, and psychoactive drug consumption).